AcouSort AB (publ) (STO:ACOU)
Sweden · Delayed Price · Currency is SEK 3.720
+0.170 (4.79%)
Jul 24, 2026, 4:41 PM CET
AcouSort AB Market Cap
AcouSort AB has a market cap or net worth of 75.13 million as of July 24, 2026. Its market cap has increased by 1.43% in one year.
Market Cap
75.13M
Enterprise Value
60.56M
Revenue
10.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.72
ChartMarket Cap Chart
Since January 9, 2017, AcouSort AB's market cap has increased from 65.36M to 75.13M, an increase of 14.95%. That is a compound annual growth rate of 1.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 75.13M | 25.44% |
| Dec 30, 2025 | 59.89M | -63.54% |
| Dec 30, 2024 | 164.28M | -29.12% |
| Dec 29, 2023 | 231.76M | 18.13% |
| Dec 30, 2022 | 196.19M | -41.95% |
| Dec 30, 2021 | 337.98M | 24.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biovica International AB | 131.36M |
| Alligator Bioscience AB | 123.49M |
| OncoZenge AB | 105.22M |
| Alzinova AB | 102.27M |
| Annexin Pharmaceuticals AB | 88.24M |
| Spago Nanomedical AB | 75.42M |
| Ascelia Pharma AB | 68.10M |
| Pila Pharma AB | 58.02M |